Surgical ablation for atrial fibrillation as a concomitant cardiac surgery procedure. A single-centre study with 1-year follow-up  by Mach, Lukas et al.
Original research article
Surgical ablation for atrial fibrillation as a
concomitant cardiac surgery procedure.
A single-centre study with 1-year follow-up
Lukas Mach a, Vladimir Horvath a,b, Eva Jakubcova a, Katarina Kovacicova c,
Zdenko Kasac c, Petr Nemec a,b, Tomas Konecny a,d, Marek Orban a,b,*
a International Clinical Research Centre, St. Anne's University Hospital Brno, Pekarska 53, Brno 65691, Czech Republic
bCentre of Cardiovascular Surgery and Transplantation Brno, Pekarska 53, Brno 65691, Czech Republic
cMasaryk University, Kamenice 5, Brno 62500, Czech Republic
dDivision of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 3 2 3 – e 3 2 8
a r t i c l e i n f o
Article history:
Received 24 February 2015
Received in revised form
3 March 2015
Accepted 4 March 2015
Available online 3 April 2015
Keywords:
Surgical ablation
Atrial ﬁbrillation
a b s t r a c t
Introduction: Surgical ablation procedures have been shown to be effective in treatment of
atrial ﬁbrillation (AF), but convincing evidence showing relationship between clinical con-
founders, surgical technique and intermediate-to-long  term outcomes is still lacking.
Therefore we conducted a retrospective single-centre database study to identify predictors
of sinus rhythm (SR) maintenance at 12 months after surgery with insights into standard
medical care provided by general practitioners and/or outpatient cardiologists in the setting
of a newly introduced method.
Methods: Data from consecutive 376 patients, who underwent heart surgery which included
surgical left atrial (LA) ablation for AF between July 2006 and December 2010, were collected.
Primary outcome was maintenance of SR at 12 months. A stepwise backward multivariate
logistic regression analysis was used to identify predictors of the primary outcome.
Results: RF ablation was performed in 210 patients and 166 patients underwent cryoablation.
In 273 subjects the 12-month follow-up data were available. The success rate in maintaining
the sinus rhythm 1 year after surgery was 48.9% (63.1% for cryoablation, and 37.8% for RF
(p < 0.0001)). None of the patients underwent repeated ablation procedure within the
12-month follow-up period. Paroxysmal AF, mitral valve surgery, and smaller LA diameter
were associated with the primary endpoint; cryoablation was superior to RF ablation.
Nevertheless, prescription rate of amiodarone/propafenone  in patients with documented
sinus rhythm at 12-month follow-up was 36.0%.
Conclusions: Using multivariate analysis of retrospective data we identiﬁed clinical confoun-
ders and technical aspects associated with better outcomes after surgical ablation for AF.
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Surgical ablation procedures have been shown to be effective
in treatment of atrial ﬁbrillation (AF) and are considered a
valuable option especially for patients requiring a cardiac
surgery for other reasons such as valvular and/or ischaemic
heart diseases [1–3]. Various lesion sets and energy sources
have evolved and now have largely replaced the traditional
cut-and-sew method [4,5], but convincing evidence about
relationship between surgical technique, clinical confounders,
and intermediate-to-long term outcomes is still lacking.
The ambiguity in comparing the individual approaches to
the surgical ablations might be due to unclear, non-uniform
criteria for heart rhythm outcome evaluation as seen in many
studies [1,6,7]. Similarly, the intra- and inter-centre differences
of patient populations undergoing these procedures inﬂuence
interpretation of outcomes and limit power of conclusions [6].
Results of a single-centre retrospective database analysis are
presented and discussed in this manuscript. The study was
aimed to contribute to ongoing discussion regarding the surgical
technique, and also the inﬂuence of left atrial (LA) diameter on
sinus rhythm (SR) maintenance at 12 months after surgery.
Methods
All the patients who underwent heart surgery which included
surgical left atrial (LA) ablation for AF between July 2006 and
December 2010 in our centre were identiﬁed by procedure
codes, and relevant data were collected from their electronic
medical records in our institution. Patients who underwent
biatrial ablation for AF were not included in this study since
our institution had only a limited number of such cases in the
study period. Primary outcome was maintenance of SR at
12 months after surgery validated by electrocardiogram and/or
24-h Holter monitoring.
Surgical technique
The energy sources used to create transmural lesions in the LA
were either bipolar radiofrequency (RF) energy or cryothermy.
Isolator® SynergyTM Ablation System by AtriCure® was used to
apply RF energy whereas cryothermy was administered by
Cardioblate® CryoFlexTM Argon-Powered Surgical Ablation Sys-
tem by Medtronic. The choice of energy source in each individual
case was in competence of the operating cardiac surgeon.
Lesion set in the left atrium comprised of isolation lines
around ostia of pulmonary veins bilaterally, a line connecting
the left and right pulmonary veins, and a connecting lesion to
the left atrial appendage which was resected. With the
cryoablation technique a lesion to the mitral valve annulus
was added. This was not performed in RF technique due to risk
of damage of structures in the coronary sulcus [8,9]. Cryoabla-
tion lesions in patients undergoing mitral valve surgery were
performed from the endocardial approach while the other
patients were ablated from the epicardial surface.
Unless postoperative bradycardia occurred the patients
were commenced on amiodarone treatment after surgery and
electrical cardioversion was added if necessary. A standard3-month course of antiarrhythmic drug treatment therapy was
recommended, but it was left to supervision of the referring
cardiologist and/or GP. A follow-up scheme consisting of
3-month and 6-month consultations at the referring cardiologist
ofﬁce, and a 12-month check-up at our facility was proposed to
the patients unless clinical circumstances required otherwise.
Depending on outcome of the 12-month evaluation at our
centre, most patients were recommended to continue with
clinical ambulatory care by their referring cardiologist and/or GP.
Follow-up data
The primary outcome – restoration and maintenance of sinus
rhythm at 12 months after surgery – was validated by
physician's ofﬁce 12-lead electrocardiogram. 24-h Holter moni-
toring of ECG at 3 and 6 months was recommended in the
follow-up instructions, but the decision whether or not to
perform Holter monitoring was entirely in competence of the
referring cardiologist/GP, prior to the follow-up consultation at
our facility. The primary endpoint was met if the patient was
free from AF, atrial ﬂutter (AFL), and atrial tachycardia (AT) [1]
and had not undergone pacemaker implantation by the time of
the follow-up evaluation.
Hearth rhythm assessment was performed in our facility
on the occasion of 1-year post-operative check-up. In patients
who did not present for follow-up evaluation we obtained ECG
records through their primary care physician's ofﬁce. Infor-
mation regarding patients' follow-up medication was obtained
by the same means. The mortality data were collected through
the general medical insurance registry of the Czech Republic.
Since a signiﬁcant portion of the postoperative care
between the surgical intervention and the follow-up appoint-
ment was provided by outside facilities, we were unable to
obtain detailed history to assess if the criteria for antiarrhyth-
mic drug discontinuation as described in the HRS/EHRA/ECAS
Expert Consensus Statement were met [1]. Therefore we opted
to deﬁne our primary outcome as freedom from AF, AFL, and
AT regardless of antiarrhythmic medication (AAM).
Statistical analysis
Pearson Chi-square test, Wilcoxon rank-sum test, and
Student's t test were used to compare categorical and
continuous variables across the RF and cryoablation groups.
For stepwise backward multivariate logistic regression analy-
sis these clinical confounders were used: age, gender, type of
surgery (mitral valve surgery, tricuspid valve surgery, aortic
valve replacement, coronary artery bypass graft), type of LA
ablation (cryothermy vs. bipolar radiofrequency (RF)), surgical
ablation approach (endocardial vs. epicardial approach), type
of AF (paroxysmal vs. longstanding persistent) and LA size,
and left ventricular ejection fraction. The study was approved
by Ethics Committee of our centre and it waived the need for
patient informed consent for this retrospective study.
Results
In total 376 patients were enrolled in the study. RF ablation was
performed in 210 patients and 166 patients underwent
Fig. 1 – Usage of RF and cryoablation techniques over the
course of the study. The chart shows percentages of RF and
cryoablations in each chronological group of 100 patients.
Cryo, cryoablation; RF, radiofrequency ablation.
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varied through the study period (Fig. 1). Surgical ablation for
treatment of AF is not a primary indication for surgery in our
centre, and it was added to one or more of the following
surgical interventions: mitral valve replacement or repair
(n = 186, 49.6%), tricuspid valve replacement or repair (n = 131,
35.0%), aortic valve replacement (n = 152, 40.6%), and coronary
artery bypass graft (CABG) (n = 132, 35.3%). The most common
combinations of surgical interventions to which the surgical
ablation was added were: mitral valve + tricuspid valve
surgery (70, 18.8%); isolated aortic valve replacement
(64, 17.2%); isolated CABG (52, 14.0%); isolated mitral valveTable 1 – Preoperative characteristics of all patients.
Patients' characteristics All patients (n = 376) 
Gender (women) 161 (42.8%) 
Age (years) 69.8 (8.3) 
NYHA
I 6 (1.8%) 
II 101 (29.9%) 
III 211 (62.4%) 
IV 20 (5.9%) 
Endocardial ablation 99 (26.3%) 
Type of surgery
Mitral valve surgery 186 (49.6%) 
Tricuspid valve surgery 131 (35.0%) 
Aortic valve replacement 152 (40.6%) 
Coronary artery bypass graft 132 (35.3%) 
Type of AF before surgery
Paroxysmal 105 (27.9%) 
Longstanding persistent 271 (66.3%) 
Baseline echocardiography
Left ventricular ejection fraction 52.5 (11.7) 
Left atrial diameter 49.1 (8.3) 
Antiarrhythmic medication
Amiodarone 63 (16.9%) 
Propafenone 17 (4.6%) surgery (44, 11.8%); aortic valve replacement + CABG (33, 8.9%);
mitral valve surgery + aortic valve replacement (21, 5.6%);
mitral valve surgery + CABG (18, 4.8%); isolated tricuspid
valve surgery (14, 3.8%); mitral valve + tricuspid valve sur-
gery + CABG (14, 3.8%); and other procedures (42, 11.3%). The
baseline preoperative patients' characteristics are summa-
rized in Table 1.
Early postoperative outcomes
Upon discharge from hospital, sinus rhythm was restored in
226 (60.1%) patients undergoing surgical ablation. Postopera-
tive paroxysms of atrial ﬂutter were reported in 31 (8.2%)
patients. A 30-day post-operative mortality was 2.9%
(11 patients).
Follow-up outcomes
One-year survival after surgery was 88.3% (332 patients). In 273
(82.2%) of the surviving patients the follow-up data were
available. A major portion of the follow-up evaluations were
performed in our facility, while 27 (9.9%) of the assessments
were performed by patients' primary care physicians and then
reported to our centre.
The primary outcome, presence of sinus rhythm, was met
in 48.9% (136) of the surviving patients. Cryoablation showed
63.1% success rate, while RF ablation 37.8% (p < 0.0001).
Permanent electronic pacemaker was implanted in 19 patients
(6.8%). All of the implantations took place within 30 days after
the operation and no pacemaker implantation was required
later on. We did not identify any clinical variable which would
predict occurrence of this adverse outcome. One patient
operated for mitral valve replacement and RF ablation
underwent a heart transplant 11 months after the initialRF (n = 210) Cryoablation (n = 166) p-Value
94 (44.8%) 67 (40.4%) 0.4031
70.6 (7.5) 68.8 (9.2) 0.0391
3 (1.5%) 3 (2.0%) 1
59 (31.2%) 42 (28.2%) 0.5525
112 (59.3%) 99 (66.4%) 0.2134
15 (7.9%) 5 (3.4%) 0.1033
0 99 (59.6%) <0.0001
87 (41.6%) 99 (59.6%) 0.0005
74 (35.6%) 57 (34.3%) 0.8279
91 (43.8%) 61 (36.8%) 0.2035
72 (34.6%) 60 (36.1%) 0.7585
49 (23.3%) 56 (33.7%)
161 (76.7%) 110 (66.3%) 0.0256
53.1 (12.1) 51.8 (11.3) 0.2426
49.3 (8.4) 49.0 (8.1) 0.7785
37 (17.8%) 26 (15.8%) 0.6023
11 (5.3%) 6 (3.6%) 0.4474
Table 3 – Antiarrhythmic medication, and anticoagulation by warfarin or non-vitamin K anticoagulants at 12 months after
surgery.
Medication at 12 months
Amiodarone Propafenone Digoxin Anticoagulation
Sinus rhythm at 12 months 45 (33.1%) 4 (2.9%) 8 (5.9%) 48 (35.3%)
Paroxysmal at 12 months 46 (71.9%) 4 (6.2%) 5 (7.8%) 62 (96.9%)
Longstanding persistent AF at 12 months 24 (32.9%) 3 (4.2%) 15 (20.8%) 73 (98.7%)
Total 115 (42.1%) 11 (4.0%) 29 (10.3%) 183 (66.8%)
Table 2 – Outcomes at 12-month follow-up evaluation.
Outcomes at 1 year after surgery All patients RF Cryoablation p-Value
Mortality 40 (10.6%) 24 (11.4%) 16 (9.6%) 0.6167
Success rate of SR maintenance 136 (48.9%) 59 (37.8%) 77 (63.1%) <0.0001
Paroxysmal AF 64 (23.4%) 38 (24.7%) 26 (21.7%) 0.5346
Longstanding persistent AF 74 (27.0%) 57 (37.01%) 17 (14.2%) <0.0001
Implanted pacemaker 19 (6.83%) 12 (7.7%) 7 (5.7%) 0.6347
Heart transplant 1 (0.4%) 1 (0.5%) 0 1
Left ventricular ejection fraction (%) 53.4 (10.9) 54.0 (10.9) 52.7 (11.0) 0.3673
Left atrial diameter (mm) 48.1 (6.9) 48.19 (6.8) 48.1 (7.1) 0.901
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months after surgery is described in Table 3.
Predictors of success
Stepwise backward multivariate logistic regression analysis
was performed in order to identify clinical confounders
associated with the primary endpoint (Fig. 2). Cryoablation
was clearly superior to RF ablation with odds ratio of 2.41
(p = 0.0021). Larger left atrial diameters (AUC = 0.58) and
longstanding persistent AF on the preoperative ECG tracing
were independently and signiﬁcantly associated with lessFig. 2 – Predictors of sinus rhythm maintenance at 12 months a
regression analysis. AF, atrial fibrillation; CI, confidence intervafreedom from AF/AFL/AT in the follow-up. Surgical procedures
which included mitral valve replacement or repair were
independently associated with greater beneﬁt from the LA
ablation, in terms of meeting the primary endpoint. Endocar-
dial approach was not independently associated with the
primary endpoint.
Discussion
We present a single-centre database study on patients
undergoing surgical ablation procedure. Based on the results,fter surgery. Multivariate stepwise backward logistic
l; LA, left atrium; OR, odds ratio; RF, radiofrequency.
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important for the electrophysiological outcome of surgical left
atrial ablation. The haemodynamic consequences of mitral
valve replacement or repair were a likely cause of higher SR
restoration and maintenance rate. Preoperative left atrial
diameter measured by transthoracic echocardiography repre-
sented a signiﬁcant determinant of surgical ablation success.
Unfortunately, our data did not allow to determine a robust
and clinically meaningful cut-off value which was a problem of
most other studies as well [10]. Nonetheless, extremely large
LA should detract from pursuing surgical LA ablations as these
patients would unlikely beneﬁt from the procedure which
would needlessly prolong the extracorporeal circulation time
with all adverse consequences [11]. The outcomes of adding
surgical LA reduction to a surgical ablation for AF in patients
with dilated LA remain inconclusive [12].
One of the most clinically relevant ﬁndings of this study
was the superiority of cryoablation to the RF ablation
technique. Even after adjusting for numerous clinical con-
founders the difference in success rate was statistically
signiﬁcant (OR = 2.41). The difference in type of ablation
energy seemed to be an unlikely explanation for this
phenomenon since both energies were previously proven to
create transmural lesions [13,14]. However, it may be that the
RF ablation technique was more prone to creating gaps
between the individual ablation lines. We may also consider
the possibility of higher rate of pulmonary vein reconnections
with the RF technique occurring within one year after surgery.
The difference in lesion sets could possibly explain the
lower SR maintenance rate at 12 months in patients after RF
ablation. The connecting line to the mitral annulus in the
cryoablation procedure might have largely prevented occur-
rence of perimitral ﬂutter a common adverse outcome of a
heart surgery and/or ablation for AF [15–17]. Nevertheless,
clinical diagnosis of perimitral ﬂutter was not established in
any of the patients. However, none of the patients in the
present series underwent an electrophysiological study within
the follow-up period and therefore the exact mechanisms of
arrhythmias arising from failed ablation procedures in this
cohort remain unclear. Furthermore, pathophysiology of AF is
complex and therefore it may be that in certain patients,
especially in those with recent onset of AF, ablation line across
the mitral isthmus may not be required for achieving long-
term freedom from AF/AFL/AT. Based on our experience
supported by data published in the literature, a connecting line
across the mitral isthmus by a cryoablation probe has been
added to the RF ablation in our institution. Furthermore,
biatrial ablation procedures which have been introduced in our
centre recently are expected to improve results in patients
with dilated right atria and tricuspid valve insufﬁciency.
The general medical insurance registry of the Czech
Republic is a highly accurate source of mortality data. The
1-year mortality rate (10.6%) was likely due to signiﬁcant
prevalence of serious comorbidities and high mean age of our
patients. No randomized or matched controls were included in
our study and therefore we cannot judge whether the surgical
ablation procedure provided a survival beneﬁt or not, but it
was not the intended objective of this report.
Randomized controlled trials addressing the area of
concomitant surgical ablations for AF are available, but mostof them suffered from small sample sizes (15–120) as only two
of them enrolled more than 45 surgical ablation patients [2].
A trial by Srivastava et al. (n = 120) compared 3 different
ablation strategies and a control, no ablation group [18].
However, this study population included only young
(<60 years) patients with chronic rheumatic atrial ﬁbrillation
undergoing valvular heart surgery  surgical ablation and
therefore had limited relevance to the practice in Europe and
North America. The PRAGUE-12 randomized multicentre
study (n = 117) conﬁrmed superiority of heart surgery with
surgical ablation to heart surgery only in terms of SR
maintenance at 1 year, but it did not address the issue of
optimal lesion set and energy source [19].
Most of the single-centre observational studies are limited
to patients undergoing mitral valve surgery with a concomi-
tant ablation for AF [20,21]. Stulak et al. presented a large
single-centre retrospective analysis which included patients
who underwent heart surgery for various congenital and
adult-acquired cardiac diseases, and which compared several
energy sources (cut and sew, cryothermy, radiofrequency, and
combination), and lesion sets (biatrial, isolated pulmonary
vein isolation, and isolated left atrial) used in their cohort [6].
Interestingly this study did not show larger LA diameter as an
independent predictor of surgical AF ablation failure. This on
the contrary came out statistically signiﬁcant in our multivar-
iate analysis.
Study limitations
The presented study is affected by limitations typical to
protocols based on retrospective analysis of observational
data. The patients were not randomized to either RF or
cryoablation, representing a potential selection bias. The
strength of the presented study is a population count which
allowed advanced statistical analysis including adjusting for
numerous clinical confounders. The main limitation is the
ambiguity regarding precise regiment of AAM in the
postoperative management. Therefore, it was not feasible
to secure evidence whether all of the patients in sinus
rhythm still using AAM at 12 months had a trial of
discontinuing AAM medication. In addition to the single-
centre design there were other possible limitations. The
absence of longer (e.g. 1 week) ECG Holter monitoring could
have affected accuracy of the results. Also patient experi-
enced symptoms without an ECG correlate were not
consistently recorded in our database and were not used
to deﬁne the primary outcome.
Relatively high prevalence of amiodarone/propafenone
prescription at 12 months after surgery could indicate need
for improved physician awareness regarding outpatient care
after surgical ablations for AF. Since the presented data were
collected during the ﬁrst years after the introduction of this
technique, it is conceivable that this fact was the major reason
of quality issues limiting the power of the results. Based on
these facts the importance of close collaboration and
professional interactions between specialized/academic cen-
tres and outpatient healthcare providers should not be
underestimated especially in the scenario of newly introduced
technique or procedure.
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Based on the single-centre study from data collected shortly
after the introduction of surgical ablation techniques in
treatment of AF, these clinical confounders were proven to
independently affect rhythm outcomes: type of ablation
(superiority of cryoablation to the RF ablation technique), type
of AF, LA diameter, and concomitant mitral valve surgery. It
appears that these should be of paramount importance when
considering adding surgical ablation to a heart surgery. Since
postoperative outpatient management respecting current
recommendations outside of a cardiothoracic centre in the
early stages is critically important, a close collaboration and
knowledge sharing among the healthcare professionals
appear to be mandatory.
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